It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Niemann-Pick type C disease is a rare neurodegenerative disorder mainly caused by mutations in NPC1, resulting in abnormal late endosomal/lysosomal lipid storage. Although microgliosis is a prominent pathological feature, direct consequences of NPC1 loss on microglial function remain not fully characterized. We discovered pathological proteomic signatures and phenotypes in NPC1-deficient murine models and demonstrate a cell autonomous function of NPC1 in microglia. Loss of NPC1 triggers enhanced phagocytic uptake and impaired myelin turnover in microglia that precede neuronal death. Npc1−/− microglia feature a striking accumulation of multivesicular bodies and impaired trafficking of lipids to lysosomes while lysosomal degradation function remains preserved. Molecular and functional defects were also detected in blood-derived macrophages of NPC patients that provide a potential tool for monitoring disease. Our study underscores an essential cell autonomous role for NPC1 in immune cells and implies microglial therapeutic potential.
Niemann-Pick type C disease is a rare childhood neurodegenerative disorder predominantly caused by mutations in NPC1, resulting in abnormal late endosomal and lysosomal defects. Here the authors show that NPC1 disruption largely impairs microglial function.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany (GRID:grid.424247.3) (ISNI:0000 0004 0438 0426)
2 German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany (GRID:grid.424247.3) (ISNI:0000 0004 0438 0426); Technical University of Munich, Neuroproteomics, School of Medicine, Klinikum rechts der Isar, Munich, Germany (GRID:grid.6936.a) (ISNI:0000000123222966)
3 Munich Cluster for Systems Neurology (SyNergy), Munich, Germany (GRID:grid.452617.3)
4 German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany (GRID:grid.424247.3) (ISNI:0000 0004 0438 0426); Technical University of Munich, Institute of Neuronal Cell Biology (TUM-NZB), Munich, Germany (GRID:grid.6936.a) (ISNI:0000000123222966)
5 German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany (GRID:grid.424247.3) (ISNI:0000 0004 0438 0426); Technical University Munich, Faculty of Chemistry, Garching, Germany (GRID:grid.6936.a) (ISNI:0000000123222966)
6 Division of Molecular Medicine, Ruder Boskovic Institute, Zagreb, Croatia (GRID:grid.4905.8) (ISNI:0000 0004 0635 7705)
7 Ludwig-Maximilians University, Department of Neurology, Munich, Germany (GRID:grid.5252.0) (ISNI:0000 0004 1936 973X); University Hospital Bern, Department of Neurology, Bern, Switzerland (GRID:grid.411656.1) (ISNI:0000 0004 0479 0855)
8 University of Michigan, Department of Pathology, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370)
9 German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany (GRID:grid.424247.3) (ISNI:0000 0004 0438 0426); Munich Cluster for Systems Neurology (SyNergy), Munich, Germany (GRID:grid.452617.3); Technical University of Munich, Institute of Neuronal Cell Biology (TUM-NZB), Munich, Germany (GRID:grid.6936.a) (ISNI:0000000123222966)
10 German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany (GRID:grid.424247.3) (ISNI:0000 0004 0438 0426); Technical University of Munich, Neuroproteomics, School of Medicine, Klinikum rechts der Isar, Munich, Germany (GRID:grid.6936.a) (ISNI:0000000123222966); Munich Cluster for Systems Neurology (SyNergy), Munich, Germany (GRID:grid.452617.3)
11 Ludwig-Maximilians University, Department of Neurology, Munich, Germany (GRID:grid.5252.0) (ISNI:0000 0004 1936 973X)